Market revenue in 2022 | USD 5,003.5 million |
Market revenue in 2030 | USD 22,357.7 million |
Growth rate | 20.6% (CAGR from 2022 to 2030) |
Largest segment | Biomedical |
Fastest growing segment | Food & beverage |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Water Treatment, Pharmaceutical, Biomedical, Cosmetics, Food & beverage |
Key market players worldwide | Lyondellbasell Advanced Polymers Inc Pref Share, Foodchem International Corporation, FMC Corp, Shell PLC, Primex Pharmaceuticals, Nanobiotix SA ADR, Dainichiseika Color & Chemicals Mfg Co Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to chitosan market will help companies and investors design strategic landscapes.
Biomedical was the largest segment with a revenue share of 36.81% in 2022. Horizon Databook has segmented the North America chitosan market based on water treatment, pharmaceutical, biomedical, cosmetics, food & beverage covering the revenue growth of each sub-segment from 2018 to 2030.
Stringent regulations, certfications and high cost associated with obtaining licenses for production of chitosan has discouraged many small scale manufactueres in the U.S. The manufacturing for chitosan in the U.S. currently seems to be confined to R&D purpose only, with many of these players moving to countries such as Canada, where regulations are more conducive.
Furthermore, elimination of stringent regulations that restricted establishment of new manufacturing units by the Government of Mexico has resulted in the development of new pharmaceutical manufacturing facilities of large scale companies including Takeda, Daiichi Ranbaxy and Astellas.
Pharmaceutical industry in Canada is considered as one of the most profitable sectors and has been the fourth fastest growing healthcare market after China, U.S. and Spain. As a result, positive pharmaceutical industry outlook in Canada is likely to fuel chitosan market demand.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America chitosan market , including forecasts for subscribers. This continent databook contains high-level insights into North America chitosan market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account